AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 417581
Drug: 4.5 g
RxNorm normalized name: Zosyn 4.5 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 g of iopronic acid
Trial: 14996516
Drug: Epinastine hydrochloride
RxNorm normalized name: Epinastine Hydrochloride
DrugBank: Epinastine (DB00751)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epinastine hydrochloride 0.05% ophthalmic solution
Trial: 19618992
Drug: Simvastatin and
RxNorm normalized name: simvastatin and ezetimibe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin and L-carnitine
Trial: 11106838
Drug: High 2-h
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High 2-h OGTT value (>9.0 mmol/l)
Trial: 6135430
Drug: GP 55
RxNorm normalized name: Zotex-GP 550mg-8.5mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GP 55 129 (4 mg)
Trial: 27514629
Drug: Supervised physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised physical exercise training with treatment as usual (TAU)
Trial: 16466609
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) 0.5 mg/2 mL bid
Trial: 16466609
Drug: Disodium cromoglycate
RxNorm normalized name: Disodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium cromoglycate (DSCG) 20 mg/2 mL tid
Trial: 19853947
Drug: Aspirin therapy
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin therapy
Trial: 10599951
Drug: Deramciclane 10
RxNorm normalized name: Deramciclane
DrugBank: Deramciclane (DB06512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deramciclane 10 mg
Trial: 11455373
Drug: Preemptive ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Preemptive ibuprofen therapy (400 mg taken orally 1 hour before separator placement and 400 mg taken orally 6 hours after the initial dose)
Trial: 31613055
Drug: Mesenchymal stem
RxNorm normalized name: Human mesenchymal stem cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesenchymal stem cells (MSCs) therapy (2 intravenous doses of 2×10^8 cells every 3 months)
Trial: 23113543
Drug: Oxaliplatin combined
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin combined with 5-fluorouracil chemotherapy or Xeloda
Trial: 19778495
Drug: Adjunctive olanzapine
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjunctive olanzapine (5 to 20 mg/d)
Trial: 9695137
Drug: Co-syntropin (ACTH1-24)
RxNorm normalized name: CO
DrugBank: Carbon monoxide (DB11588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-syntropin (ACTH1-24) 0.25 mg
Trial: 25358867
Drug: Oral paliperidone
RxNorm normalized name: Paliperidone
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral paliperidone extended release (Pali ER)
Trial: 16287344
Drug: 5.0 g
RxNorm normalized name: IODINE 5.0 g in 1 L TOPICAL SOLUTION [FS-104]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 g Cr + 18 g dextrose + 4 g of sodium and potassium phosphates (CrP)
Trial: 28844193
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy with dabigatran (150 mg twice daily)
Trial: 10902797
Drug: Leptin levels
RxNorm normalized name: leptin
DrugBank: Leptin (DB05098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leptin levels in serum (30.3 +/- 14.8 ng/mL)
Trial: 384858
Drug: 10 days
RxNorm normalized name: AlleRx 10-day Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 days of treatment with trimethoprim/sulfamethoxazole
Trial: 384858
Drug: 12 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12 weeks of treatment with trimethoprim/sulfamethoxazole
Trial: 27590374
Drug: Probiotic capsules
RxNorm normalized name: Quad-Probiotic Capsules
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic capsules containing Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14
Trial: 10802077
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g intravenous cefazolin
Trial: 21227624
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) therapy
Trial: 7621634
Drug: 18 g
RxNorm normalized name: flotufolastat F 18 gallium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 g human intravenous immunoglobulin (IVIg) every three weeks
Trial: 1870380
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of rifampicin 40 mg/K bodyweight
Trial: 1870380
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of rifampicin 1500 mg followed by one year of daily dapsone 100 mg
Trial: 20979799
Drug: Inhaled tiotropium
RxNorm normalized name: tiotropium Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled tiotropium 18 µg once daily
Trial: 2343912
Drug: 16-week treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 16-week treatment conditions (specifics not provided)
Trial: 7003855
Drug: Diethylcarbamazine (DEC)
RxNorm normalized name: diethylcarbamazine
DrugBank: Diethylcarbamazine (DB00711)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diethylcarbamazine (DEC) lotion
Trial: 22825036
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no I-131 therapy)
Trial: 22825036
Drug: I-131 therapy
RxNorm normalized name: iobenguane I-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: I-131 therapy (11.1 GBq or more)
Trial: 18285589
Drug: Biannual mass
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biannual mass azithromycin administration
Trial: 8644690
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g FOS/d
Trial: 6121479
Drug: Intravenous atenolol
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous atenolol (5 mg) followed by oral atenolol (50 mg)
Trial: 12368393
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g FOS + 1 x 10(9) cfu LAC
Trial: 10404451
Drug: Amikacin 15
RxNorm normalized name: amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin 15 mg/kg once daily
Trial: 19117316
Drug: OK-432 immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OK-432 immunotherapy (for mixed macrocystic-microcystic LM)
Trial: 3320932
Drug: Needle wiped
RxNorm normalized name: Vagisil Wipes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle wiped with sterile gauze before injection (Group 2)
Trial: 3320932
Drug: Needle changed
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle changed before injection (Group 1)
Trial: 18797097
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy (RT) + alpha-tocopherol (AT)
Trial: 31180480
Drug: Oral pregabalin
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral pregabalin during the perioperative period
Trial: 27128837
Drug: GSK961081 800 µg
RxNorm normalized name: hyaluronidase
DrugBank: Hyaluronidase (DB14740)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: GSK961081 800 µg and FP 500 µg as a blend formulation
Trial: 6873137
Drug: Scopolamine 6
RxNorm normalized name: scopolamine 6.67 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine 6 micrograms/kg (intravenous)
Trial: 31926883
Drug: Trimethoprim-Sulfamethoxazole (TMP-SMZ)
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-Sulfamethoxazole (TMP-SMZ) 160 mg/800 mg twice daily for 45 days followed by 1 dose every other day for 311 days
Trial: 21526889
Drug: Aspirin 81
RxNorm normalized name: aspirin 81 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 81 mg alone
Trial: 10969672
Drug: High-risk coronary
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-risk coronary artery bypass graft without preoperative intraaortic balloon pump therapy
Trial: 27859395
Drug: 5-aminolevulinic acid
RxNorm normalized name: 5-aminolevulinic acid
DrugBank: Aminolevulinic acid (DB00855)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-aminolevulinic acid at a dosage of 10 mg/kg, administered 3-14 hours preoperatively
Trial: 1356311
Drug: xamoterol 100
RxNorm normalized name: Xamoterol
DrugBank: Xamoterol (DB13781)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: xamoterol 100 mg two times a day
Trial: 24925090
Drug: all active
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: all active treatments
Trial: 20550533
Drug: Spironolactone 25
RxNorm normalized name: spironolactone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 25 mg once daily for 36 weeks
Trial: 2468862
Drug: 0.15 mg
RxNorm normalized name: iodine 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg clonidine (intravenously)
Trial: 12381902
Drug: Cisplatin 65
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 65 mg/m2 and methotrexate 500 mg/m2 on day 1 and Levofolinic acid 250 mg/m2 and 5‐fluorouracil 800 mg/m2 on day 2 (arm B)
Trial: 1608219
Drug: Lipostabil treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipostabil treatment
Trial: 3910730
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of piperacillin, netilmicin and cefotaxime
Trial: 15523323
Drug: Low-dose enalapril
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose enalapril
Trial: 8328566
Drug: Sustained-release alprazolam
RxNorm normalized name: alprazolam Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release alprazolam
Trial: 11405162
Drug: Intensive multidisciplinary
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive multidisciplinary training & treatment course (ISBP)
Trial: 3691273
Drug: Oral cisapride
RxNorm normalized name: Cisapride
DrugBank: Cisapride (DB00604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral cisapride
Trial: 9345414
Drug: Cladribine treatment
RxNorm normalized name: Cladribine
DrugBank: Cladribine (DB00242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cladribine treatment
Trial: 8155071
Drug: Active Low
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active Low Energy Emission Therapy (LEET)
Trial: 8155071
Drug: Inactive Low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactive Low Energy Emission Therapy (LEET)
Trial: 26330424
Drug: Pre-operative statin
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative statin therapy
Trial: 31369676
Drug: Quad-helix treatments
RxNorm normalized name: Helixate
DrugBank: Antihemophilic factor, human recombinant (DB00025)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quad-helix treatments in general dentistry (QHG)
Trial: 2501032
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin patch (20 cm2)
Trial: 2501032
Drug: All patch
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All patch sizes
Trial: 28832429
Drug: Transdermal 17β-estradiol
RxNorm normalized name: 17β-estradiol
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal 17β-estradiol (t-E2)
Trial: 3720176
Drug: Intravenous nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous nifedipine (4.5 mg in 45 minutes)
Trial: 10978398
Drug: Erythropoietin doses
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin doses in experimental group
Trial: 1285936
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg hydrochlorothiazide daily
Trial: 11998963
Drug: Oral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral therapy (conjugated equine estrogens 0.625 mg/d + medroxyprogesterone acetate 10 mg/d)
Trial: 2678520
Drug: Hydrochlorothiazide (HCT)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCT) - 25 mg
Trial: 31142156
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (HT) with conjugated estrogens/medroxyprogesterone acetate (0.30 mg/1.5 mg/d)
Trial: 29390421
Drug: Celecoxib-based chemotherapy
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib-based chemotherapy (in patients with positive COX-2)
Trial: 18439766
Drug: Postoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiation therapy (PORT) in the observation arm
Trial: 17030751
Drug: Motor Activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motor Activity Log (MAL) treatment group
Trial: 10088733
Drug: Vehicle solution
RxNorm normalized name: compounding vehicle solution sugar free no. 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle solution administered four times daily for 14 days
Trial: 10750765
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose aprotinin
Trial: 18155200
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment for complex congenital anomalies (e.g., unicornuate uterus, uterus didelphys)
Trial: 6398510
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg dihydroergotamine + 5000 U heparin
Trial: 6398510
Drug: 5000 U
RxNorm normalized name: lipase 5000 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5000 U heparin alone (controls)
Trial: 7223302
Drug: Albumin therapy
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin therapy
Trial: 20391509
Drug: Denosumab 180
RxNorm normalized name: Denosumab
DrugBank: Denosumab (DB06643)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Denosumab 180 mg
Trial: 8733039
Drug: Felodipine 2.5
RxNorm normalized name: felodipine 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 2.5 mg once daily
Trial: 20876405
Drug: Pine bark
RxNorm normalized name: pine bark extract
DrugBank: Maritime pine extract (DB15786)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pine bark extract (200 mg/day)
Trial: 19150139
Drug: Oxycodone/acetaminophen (O/A)
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone/acetaminophen (O/A)
Trial: 6874173
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g of potassium‐magnesium aspartate over a 24‐h period
Trial: 6874173
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g of potassium‐magnesium aspartate
Trial: 19378582
Drug: Intravenous clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous clonidine (2.5 microg.kg(‐1))
Trial: 1706282
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg of octreotide acetate subcutaneously before pancreatography
Trial: 30873657
Drug: Acetazolamide therapy
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide therapy for 6 months
Trial: 25017924
Drug: Oral low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral low-dose hormone therapy (estradiol 1 mg + drospirenone 2 mg/day) for 3 months
Trial: 20642918
Drug: Walking epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Walking epidural analgesia with 15 ml of 0.1% Bupivacaine + 0.5 mg/ml Tramadol
Trial: 29726480
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside (200 μg injected into the coronary artery)
Trial: 16107035
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no medication affecting coagulation)
Trial: 12130970
Drug: H2-blockers
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: H2-blockers
Trial: 25088963
Drug: Denosumab 60mg
RxNorm normalized name: DENOSUMAB 60MG/ML INJ
DrugBank: Denosumab (DB06643)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Denosumab 60mg subcutaneous injections twice yearly
Trial: 19906002
Drug: estradiol valerate
RxNorm normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: estradiol valerate 2 mg + placebo (E/P)
Trial: 6780998
Drug: 96 mg
RxNorm normalized name: camphor 96 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 96 mg of inhaled cocaine
Trial: 8284070
Drug: Ibuprofen 200
RxNorm normalized name: ibuprofen 200 MG
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen 200 mg
Trial: 22038349
Drug: Tiotropium bromide
RxNorm normalized name: Tiotropium Bromide
DrugBank: Tiotropium (DB01409)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiotropium bromide inhalation (18 μg/day)
Trial: 18647853
Drug: Tablet PC
RxNorm normalized name: PCS-499
DrugBank: PCS-499 (DB15122)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet PC self-administered questionnaires
Trial: 2677374
Drug: H142 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H142 at 2.5 mg/kg/h
Trial: 3899772
Drug: Prenylamine 60
RxNorm normalized name: prenylamine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenylamine 60 mg t.i.d.
Trial: 20730486
Drug: Post-treatment fracture
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-treatment fracture rates
Trial: 6761102
Drug: High calorie
RxNorm normalized name: High calorie formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High calorie daily supplement (800 kcal and 40 g protein)
Trial: 16244028
Drug: Alkalinized lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alkalinized lidocaine with 8.4% NaHCO3 (group large dose)
Trial: 24992294
Drug: Atazanavir/ritonavir 300/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atazanavir/ritonavir 300/100 mg once daily
Trial: 14722892
Drug: Lopinavir/ritonavir 400/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir/ritonavir 400/100 mg twice daily
Trial: 28993264
Drug: Muscarinic-antagonist component
RxNorm normalized name: 1,3-beta-glucan synthase component FKS1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muscarinic-antagonist component (umeclidinium - UME)
Trial: 15673389
Drug: Autonomic tone
RxNorm normalized name: docusate
DrugBank: Docusate (DB11089)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autonomic tone inhibition (ATI) with propranolol (0.15 mg/kg) and atropine (0.02 mg/kg)
Trial: 25765835
Drug: Silymarin supplementation
RxNorm normalized name: silymarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin supplementation (140 mg, thrice daily for 45 days)
Trial: 9273185
Drug: Concomitant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant chemotherapy and radiotherapy (cisplatin 50 mg/m2 on days 1 and 2, fluorouracil 1 gr/m2 continuous infusion on days 1, 2, and 3, external beam irradiation 20 Gy in 2 Gy fractions from days 1 to 12)
Trial: 12612294
Drug: Montelukast 10
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 10 mg once daily for 16 weeks